← Back to Search

Behavioral Intervention

Smart Healthcare Technology for Alzheimer's Caregiver Support

N/A

Waitlist Available

Led By Karen M Rose, PhD

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up daily through study completion, average of 4 months

Awards & highlights

Study Summary

This trial aims to develop a solution that monitors a dementia patient's mood and stress, as well as the caregiver's behavior. The goal is to help improve familial interactions related to caregiving, which over time should reduce strain on caregivers.

Who is the study for?

This trial is for men and women aged 60-90 with documented dementia, including Alzheimer's, who live at home and speak English. Caregivers must be over 21, living with the patient, not paid for their care work, have functioning home Wifi, and experience a certain level of stress as measured by a clinical checklist.Check my eligibility

What is being tested?

The study tests a smart healthcare system that monitors mood and stress in both patients with dementia and their caregivers. It uses machine learning to understand interaction dynamics and provides adaptive recommendations to improve caregiver-patient relationships.See study design

What are the potential side effects?

Since this intervention involves monitoring systems rather than medications or invasive procedures, traditional physical side effects are not expected. However, there may be privacy concerns or emotional impacts from constant monitoring.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Acoustic Monitoring/Mood Classifier

Change in Caregiver Depression, Anxiety and Stress

Change in Caregiver Loneliness

+10 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Dementia/Caregiver DyadExperimental Treatment1 Intervention

All dementia/caregiver dyads will have in-home acoustic monitoring to classify mood and will be provided mindfulness-based stress reduction recommendations via a smart phone.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Tennessee, KnoxvilleOTHER

83 Previous Clinical Trials

18,459 Total Patients Enrolled

Ohio State UniversityLead Sponsor

829 Previous Clinical Trials

505,643 Total Patients Enrolled

University of VirginiaOTHER

754 Previous Clinical Trials

1,244,973 Total Patients Enrolled

Media Library

Mood Monitoring and Behavioral Recommendation System (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04536701 — N/A

Alzheimer's Disease Research Study Groups: Dementia/Caregiver Dyad

Alzheimer's Disease Clinical Trial 2023: Mood Monitoring and Behavioral Recommendation System Highlights & Side Effects. Trial Name: NCT04536701 — N/A

Mood Monitoring and Behavioral Recommendation System (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04536701 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial open to those younger than twenty years old?

"This trial's enrollment criteria indicate that patients must be between 21 and 99 years old. There are 23 other trials available to minors, while 543 clinical studies target those over 65."

Answered by AI

Are there any openings left to join this experiment?

"Affirmative. As per the information on clinicaltrials.gov, this medical trial is currently recruiting applicants. It first appeared online in February 2021 and was last updated in April 2022. The study necessitates 100 individuals from a single research centre to be enrolled."

Answered by AI

May I qualify for participation in this medical study?

"The desired enrollees for this trial should have a diagnosis of Alzheimer's disease and be between 21 and 99 years old. The aim is to recruit approximately 100 participants in total."

Answered by AI

To what extent is the participant pool for this research project expanding?

"Yes, according to clinicaltrials.gov, this trial is still accepting participants. The study was first published on February 19th 2021 and the most recent update occurred April 19th 2022 - 100 patients are needed from a single site."

Answered by AI

Recent research and studies

Journal of Advanced NursingJournal

Smarthealth Technology Study Protocol to Improve Relationships Between Older Adults with Dementia and Family Caregivers

Rose, Karen M., Kristina Coop Gordon, Emma C. Schlegel, Matthew Mccall, Ye Gao, Meiyi Ma, Katherine A. Lenger, et al.. 2021. “Smarthealth Technology Study Protocol to Improve Relationships Between Older Adults with Dementia and Family Caregivers”. Journal of Advanced Nursing. Wiley. doi:10.1111/jan.14714.

clinicaltrials.govStudy

Learning and Improving Alzheimer's Patient-Caregiver Relationships Via Smart Healthcare Technology

Karen Rose 2021. "Learning and Improving Alzheimer's Patient-Caregiver Relationships Via Smart Healthcare Technology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04536701.